Sarcoglycan subcomplex in normal human smooth muscle: an immunohistochemical and molecular study.

PubWeight™: 0.79‹?›

🔗 View Article (PMID 16077941)

Published in Int J Mol Med on September 01, 2005

Authors

Giuseppe Anastasi1, Giuseppina Cutroneo, Antonina Sidoti, Giuseppe Santoro, Rosalia D'Angelo, Giuseppina Rizzo, Carmen Rinaldi, Oddone Giacobbe, Placido Bramanti, Giuseppe Navarra, Aldo Amato, Angelo Favaloro

Author Affiliations

1: Dipartimento di Biomorfologia e Biotecnologie, Policlinico Universitario, Università degli Studi di Messina, Torre Biologica, Italy.

Articles by these authors

New technique for liver resection using heat coagulative necrosis. Ann Surg (2002) 3.13

How we do a bloodless partial splenectomy. Am J Surg (2003) 2.26

Impact of hepatitis B virus (HBV) preS/S genomic variability on HBV surface antigen and HBV DNA serum levels. Hepatology (2012) 1.92

Transcatheter closure of congenital ventricular septal defects: results of the European Registry. Eur Heart J (2007) 1.89

Ultrasound-guided radiofrequency-assisted segmental liver resection: a new technique. Ann Surg (2009) 1.60

Misdiagnosed chronic pelvic pain: pudendal neuralgia responding to a novel use of palmitoylethanolamide. Pain Med (2010) 1.54

Horner syndrome following thyroidectomy. Neurol Sci (2010) 1.43

Recurrent occipital seizures misdiagnosed as status migrainosus. Epileptic Disord (2011) 1.42

Fibromuscular dysplasia as a rare cause of severe ischemic stroke in a young man. Arq Neuropsiquiatr (2011) 1.39

Single tonic-clonic seizure after energy drink abuse. Epilepsy Behav (2012) 1.39

A case of topiramate-induced epistaxis. Curr Drug Saf (2009) 1.37

CYP4F2 genetic variant (rs2108622) significantly contributes to warfarin dosing variability in the Italian population. Pharmacogenomics (2009) 1.32

Purinergic signalling in inflammation of the central nervous system. Trends Neurosci (2009) 1.32

Occult hepatitis B virus in liver tissue of individuals without hepatic disease. J Hepatol (2008) 1.31

Molecular pathways in cancer-related inflammation. Biochem Med (Zagreb) (2011) 1.28

Immunomodulatory effects of etanercept in an experimental model of spinal cord injury. J Pharmacol Exp Ther (2005) 1.25

Regulation of dendritic cell migration and adaptive immune response by leukotriene B4 receptors: a role for LTB4 in up-regulation of CCR7 expression and function. Blood (2006) 1.23

Hepatectomy using intraoperative ultrasound-guided radiofrequency ablation. Int Surg (2003) 1.17

Sleep disorders in children with Attention-Deficit/Hyperactivity Disorder (ADHD) recorded overnight by video-polysomnography. Sleep Med (2009) 1.13

The emerging role for chemokines in epilepsy. J Neuroimmunol (2010) 1.12

Effects of palmitoylethanolamide on signaling pathways implicated in the development of spinal cord injury. J Pharmacol Exp Ther (2008) 1.12

Impairment of ceramide synthesis causes a novel progressive myoclonus epilepsy. Ann Neurol (2014) 1.11

The invisible cholecystectomy: a different way. Surg Endosc (2008) 1.11

Attenuation in the evolution of experimental spinal cord trauma by treatment with melatonin. J Pineal Res (2005) 1.11

The P2Y-like receptor GPR17 as a sensor of damage and a new potential target in spinal cord injury. Brain (2009) 1.07

Antiplatelet versus anticoagulation therapy after extracardiac conduit Fontan: a systematic review and meta-analysis. Pediatr Cardiol (2010) 1.07

Nevirapine-induced hepatotoxicity and pharmacogenetics: a retrospective study in a population from Mozambique. Pharmacogenomics (2010) 1.06

Intrathecal clonidine administration and erectile dysfunction: what is the link? Pain Physician (2013) 1.06

Evaluation of olfactory dysfunction in neurodegenerative diseases. J Neurol Sci (2012) 1.06

Octreotide in the treatment of lymphorrhea after axillary node dissection: a prospective randomized controlled trial. J Am Coll Surg (2003) 1.06

TNF-alpha blockage in a mouse model of SCI: evidence for improved outcome. Shock (2008) 1.05

Phenotypic changes, signaling pathway, and functional correlates of GPR17-expressing neural precursor cells during oligodendrocyte differentiation. J Biol Chem (2011) 1.05

Comparison of different MR venography techniques for detecting transverse sinus stenosis in idiopathic intracranial hypertension. J Neurol (2005) 1.05

CD56(bright)perforin(low) noncytotoxic human NK cells are abundant in both healthy and neoplastic solid tissues and recirculate to secondary lymphoid organs via afferent lymph. J Immunol (2014) 1.04

Glycogen synthase kinase-3 beta inhibition reduces secondary damage in experimental spinal cord trauma. J Pharmacol Exp Ther (2006) 1.03

Involvement of gD/HVEM interaction in NF-kB-dependent inhibition of apoptosis by HSV-1 gD. Biochem Pharmacol (2008) 1.02

CGS 21680, an agonist of the adenosine (A2A) receptor, decreases acute lung inflammation. Eur J Pharmacol (2011) 1.01

Effect of Apocynin, an inhibitor of NADPH oxidase, in the inflammatory process induced by an experimental model of spinal cord injury. Free Radic Res (2010) 1.01

Myrtucommulone from Myrtus communis exhibits potent anti-inflammatory effectiveness in vivo. J Pharmacol Exp Ther (2008) 1.01

Atrial function after surgical and percutaneous closure of atrial septal defect: a strain rate imaging study. J Am Soc Echocardiogr (2005) 1.00

Role of mitochondria and reactive oxygen species in dendritic cell differentiation and functions. Free Radic Biol Med (2008) 1.00

Combined treatment of Favre-Racouchot syndrome with a superpulsed carbon dioxide laser: report of 50 cases. Dermatol Ther (2010) 1.00

Glycogen synthase kinase-3beta inhibition attenuates the development of ischaemia/reperfusion injury of the gut. Intensive Care Med (2007) 1.00

Evidence for the role of PI(3) -kinase-AKT-eNOS signalling pathway in secondary inflammatory process after spinal cord compression injury in mice. Eur J Neurosci (2011) 1.00

Effect of apocynin, a NADPH oxidase inhibitor, on acute lung inflammation. Biochem Pharmacol (2010) 1.00

Mutation analysis of CCM1, CCM2 and CCM3 genes in a cohort of Italian patients with cerebral cavernous malformation. Brain Pathol (2010) 0.97

Evidence for the role of peroxisome proliferator-activated receptor-beta/delta in the development of spinal cord injury. J Pharmacol Exp Ther (2010) 0.97

Anti-inflammatory effect of simvastatin in an experimental model of spinal cord trauma: involvement of PPAR-α. J Neuroinflammation (2012) 0.96

MK801 attenuates secondary injury in a mouse experimental compression model of spinal cord trauma. BMC Neurosci (2011) 0.96

Effect of 17beta-estradiol on signal transduction pathways and secondary damage in experimental spinal cord trauma. Shock (2008) 0.96

Early and late outcome after surgery for colorectal cancer: elective versus emergency surgery. Tumori (2003) 0.95

Acute metabolic brain changes following traumatic brain injury and their relevance to clinical severity and outcome. J Neurol Neurosurg Psychiatry (2006) 0.95

Absence of endogenous interleukin-10 enhances secondary inflammatory process after spinal cord compression injury in mice. J Neurochem (2009) 0.95

Lennox-Gastaut syndrome with late-onset and prominent reflex seizures in trisomy 21 patients. Epilepsia (2009) 0.94

The EURO-NOTES clinical registry for natural orifice transluminal endoscopic surgery: a 2-year activity report. Surg Endosc (2013) 0.94

Prescribing pattern of anti-epileptic drugs in an Italian setting of elderly outpatients: a population-based study during 2004-07. Br J Clin Pharmacol (2010) 0.94

Membrane transfer from tumor cells overcomes deficient phagocytic ability of plasmacytoid dendritic cells for the acquisition and presentation of tumor antigens. J Immunol (2013) 0.94

NMDA receptor antagonist felbamate reduces behavioral deficits and blood-brain barrier permeability changes after experimental subarachnoid hemorrhage in the rat. J Neurotrauma (2007) 0.94

Bosentan-sildenafil association in patients with congenital heart disease-related pulmonary arterial hypertension and Eisenmenger physiology. Int J Cardiol (2010) 0.94

Beneficial effects of FeTSPP, a peroxynitrite decomposition catalyst, in a mouse model of spinal cord injury. Free Radic Biol Med (2007) 0.94

Effects of a metalloporphyrinic peroxynitrite decomposition catalyst, ww-85, in a mouse model of spinal cord injury. Free Radic Res (2009) 0.93

Heterogeneous seizure manifestations in Hypomelanosis of Ito: report of four new cases and review of the literature. Neurol Sci (2009) 0.93

Sexual dysfunction in male patients with multiple sclerosis: a need for counseling! Int J Neurosci (2013) 0.93

Does pilocarpine-induced epilepsy in adult rats require status epilepticus? PLoS One (2009) 0.92

Modulation of nitric oxide homeostasis in a mouse model of spinal cord injury. J Neurosurg Spine (2006) 0.92

Role of natural killer cells in the pathogenesis and progression of multiple sclerosis. Pharmacol Res (2007) 0.92

Comparison of strain rate imaging for quantitative evaluation of regional left and right ventricular function after surgical versus percutaneous closure of atrial septal defect. Am J Cardiol (2005) 0.92

Increased oxidative-related mechanisms in the spinal cord injury in old rats. Neurosci Lett (2005) 0.91

Inhibitors of poly(ADP-ribose) polymerase modulate signal transduction pathways and secondary damage in experimental spinal cord trauma. J Pharmacol Exp Ther (2004) 0.91

Glucocorticoid-induced tumor necrosis factor receptor-related (GITR)-Fc fusion protein inhibits GITR triggering and protects from the inflammatory response after spinal cord injury. Mol Pharmacol (2008) 0.91

Costameric proteins in human skeletal muscle during muscular inactivity. J Anat (2008) 0.91

Selective adenosine A2A receptor agonists and antagonists protect against spinal cord injury through peripheral and central effects. J Neuroinflammation (2011) 0.91

Altered cytoskeletal structure of smooth muscle cells in ureteropelvic junction obstruction. J Urol (2011) 0.91

Isolated endometriosis on the rectus abdominis muscle in women without a history of abdominal surgery: a rare and intriguing finding. J Minim Invasive Gynecol (2009) 0.90

Modulation of NADPH oxidase activation in cerebral ischemia/reperfusion injury in rats. Brain Res (2010) 0.90

Liver X receptor agonist treatment regulates inflammatory response after spinal cord trauma. J Neurochem (2009) 0.90

CGS 21680, an agonist of the adenosine (A2A) receptor, reduces progression of murine type II collagen-induced arthritis. J Rheumatol (2011) 0.90

1H-MR spectroscopy in traumatic brain injury. Neurocrit Care (2011) 0.90

Prolonged blockade of NMDA or mGluR5 glutamate receptors reduces nigrostriatal degeneration while inducing selective metabolic changes in the basal ganglia circuitry in a rodent model of Parkinson's disease. Neurobiol Dis (2005) 0.90

The diffuse chemosensory system: exploring the iceberg toward the definition of functional roles. Prog Neurobiol (2010) 0.89

The effects of oleuropein aglycone, an olive oil compound, in a mouse model of carrageenan-induced pleurisy. Clin Nutr (2011) 0.89

Sarcoglycan subcomplex expression in refluxing ureteral endings. J Urol (2008) 0.89

Dystrophin-glycoprotein complex and vinculin-talin-integrin system in human adult cardiac muscle. Int J Mol Med (2009) 0.89

Endothelial cell function in patients with Down's syndrome. Am J Cardiol (2004) 0.88

Abnormal regional myocardial deformation properties and increased aortic stiffness in normotensive patients with aortic coarctation despite successful correction: an ABPM, standard echocardiography and strain rate imaging study. Clin Sci (Lond) (2007) 0.88

Changing spectrum and outcome of 705 fetal congenital heart disease cases: 12 years, experience in a third-level center. J Cardiovasc Med (Hagerstown) (2008) 0.88

Ethyl pyruvate reduces the development of zymosan-induced generalized inflammation in mice. Crit Care Med (2009) 0.88